AlphaStreet had earlier reported that Apple (AAPL) is expected to launch three new iPhone models this year. In the latest update, we have learned that Apple might launch another three iPhone models in 2019, with all three featuring OLED screens. Speculations are also rife that the tech giant might consider making its own microLED display.
Following the report that appeared in South Korea’s Electronic Times, shares of iPhone display suppliers fell in Asian markets. Manufacturers are struggling to mass produce OLEDs as most of them are into LCD supply. Currently, only iPhone X features OLED screen, while LCD screens are being used in iPhone 8 and iPhone 8 Plus models.
Meanwhile, many market analysts believe Apple should focus on bringing cheaper iPhone models with LCD screens, rather than investing in microLED displays, which are very difficult to produce due to the use of millions of individual pixels and sub-pixels. However, it is expected that Apple might come out with a prototype of its microLED screen during the Worldwide Developer Conference (WWDC) 2018 to be held on June 4. Though OLEDs have most of the features of microLEDs, the latter could give high brightness and color saturation.
It is also speculated that Apple will lower the new iPhone prices by as much as $100 and the phone will come with an 18-watt USB-C fast charger. The current models come with a 5W USB-A charger. There are also chances that Apple might do away with its display notch completely.
Apart from the display, the WWDC 2018 is likely to see a slew of other launches including iOS12, macOS 10.14, tvOS 12, watchOS 5 and possible improvements to Siri and HomePod.
Three iPhones this year
This year, Apple will likely bring out three models of iPhone that will have 7-nanometer A12 chipset along with 2.6 or 2.8 GHz octa-core CPU processor and Apple Custom GPU. The updates to iPhone X and a plus-size variant are expected to have OLED screens, while a low-priced device with LCD display is also on cards.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
